Rheumatoid arthritis (RA) is a chronic inflammatory disease characteri
zed by infiltration of mononuclear cells, mainly T lymphocytes, into t
he synovial membrane (SM). The interaction of peripheral blood T cells
with the different components of the rheumatoid synovium is mediated
by cell surface proteins such as selectins, integrins, members of the
immunoglobulin superfamily and homing receptors. T lymphocytes infiltr
ating the rheumatoid SM show an activated phenotype and display an inc
reased avidity of their adhesion receptors that results in an enhanced
interaction of these cells with both extracellular matrix proteins (E
CM) and cellular ligands (VCAM-1, ICAMs). The interaction of T cell in
tegrins with their ligands, besides an additional antigenic stimulus,
could trigger a mitogenic response on these cells, a phenomenon that c
an contribute to increased cellularity observed into the rheumatoid SM
. Moreover, cell attachment to ECM through integrins induces the secre
tion of several proteases that can contribute to the tissue damage obs
erved in RA. The increased knowledge about the role of adhesion recept
ors in the pathogenesis of RA and other inflammatory diseases will all
ow the introduction of a new therapeutic approach by: the use of speci
fic blocking reagents designed to interfere with the function of adhes
ion molecules.